FR2408608A1 - Nouvel antibiotique denomme ps-5 et ses derives doues d'activite inhibitrice de la b-lactamase et leur procede de preparation - Google Patents

Nouvel antibiotique denomme ps-5 et ses derives doues d'activite inhibitrice de la b-lactamase et leur procede de preparation

Info

Publication number
FR2408608A1
FR2408608A1 FR7809644A FR7809644A FR2408608A1 FR 2408608 A1 FR2408608 A1 FR 2408608A1 FR 7809644 A FR7809644 A FR 7809644A FR 7809644 A FR7809644 A FR 7809644A FR 2408608 A1 FR2408608 A1 FR 2408608A1
Authority
FR
France
Prior art keywords
inhibitoring
lactamase
derivatives
activity
preparation process
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7809644A
Other languages
English (en)
Other versions
FR2408608B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanraku Ocean Co Ltd
Original Assignee
Sanraku Ocean Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP52035375A external-priority patent/JPS604719B2/ja
Priority claimed from JP9465177A external-priority patent/JPS5430195A/ja
Application filed by Sanraku Ocean Co Ltd filed Critical Sanraku Ocean Co Ltd
Publication of FR2408608A1 publication Critical patent/FR2408608A1/fr
Application granted granted Critical
Publication of FR2408608B1 publication Critical patent/FR2408608B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

NOUVEAUX ANTIBIOTIQUES, LEUR PREPARATION ET LEURS UTILISATIONS THERAPEUTIQUES. CES COMPOSES REPONDENT A LA FORMULE: (CF DESSIN DANS BOPI) DANS LAQUELLE R REPRESENTE L'HYDROGENE, UN GROUPE ALKYLE INFERIEUR OU TRIPHENYLMETHYLE; EVENTUELLEMENT A L'ETAT DE SEL, LORSQUE R REPRESENTE UN ATOME D'HYDROGENE. CES COMPOSES ONT DES COMPOSES ANTIBIOTIQUES EXPLOITABLES EN THERAPEUTIQUE.
FR7809644A 1977-03-31 1978-03-31 Nouvel antibiotique denomme ps-5 et ses derives doues d'activite inhibitrice de la b-lactamase et leur procede de preparation Expired FR2408608B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP52035375A JPS604719B2 (ja) 1977-03-31 1977-03-31 β‐ラクタマーゼ阻害活性を有する抗生物質ＰＳ―５の製造方法
JP9465177A JPS5430195A (en) 1977-08-09 1977-08-09 Antibiotic substance ps-5 having beta-lactamase inhibiting activity, its derivative and their preparation

Publications (2)

Publication Number Publication Date
FR2408608A1 true FR2408608A1 (fr) 1979-06-08
FR2408608B1 FR2408608B1 (fr) 1986-05-16

Family

ID=26374352

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7809644A Expired FR2408608B1 (fr) 1977-03-31 1978-03-31 Nouvel antibiotique denomme ps-5 et ses derives doues d'activite inhibitrice de la b-lactamase et leur procede de preparation

Country Status (21)

Country Link
US (1) US4318916A (fr)
AR (1) AR219738A1 (fr)
AT (1) AT362059B (fr)
AU (1) AU518781B2 (fr)
CA (1) CA1123767A (fr)
CH (1) CH643262A5 (fr)
DE (1) DE2813922A1 (fr)
DK (1) DK144098C (fr)
FI (1) FI59813C (fr)
FR (1) FR2408608B1 (fr)
GB (1) GB1598062A (fr)
GR (1) GR62185B (fr)
IE (1) IE46369B1 (fr)
IL (1) IL54118A (fr)
IT (1) IT1113066B (fr)
LU (1) LU79351A1 (fr)
NL (1) NL7802976A (fr)
NO (1) NO781076L (fr)
NZ (1) NZ186830A (fr)
PT (1) PT67848B (fr)
SE (1) SE7803623L (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2965394D1 (en) 1978-11-01 1983-06-16 Sanraku Ocean Co Process for producing antibiotic beta-lactam compounds
DE3146190A1 (de) * 1981-11-21 1983-06-16 Hoechst Ag, 6230 Frankfurt Isolierung von chemisch instabilen antibiotika aus fermentationsloesungen
US5650290A (en) * 1994-04-01 1997-07-22 Hach Company Method & Medium for use in detecting E. coli and total coliforms
US5849515A (en) * 1994-04-01 1998-12-15 Hach Company Method and medium for use in detecting E. coli and total coliforms
KR100379075B1 (en) * 2002-03-07 2003-04-08 Jinis Biopharmaceuticals Co Method for producing low cholesterol animal food product and food product therefrom
FI20205368A1 (en) * 2020-04-07 2021-10-08 Aalto Univ Foundation Sr FORMULATION
CN111826334A (zh) * 2020-07-24 2020-10-27 暨南大学 一种超长大肠杆菌及其制备方法与应用
CN113960188B (zh) * 2021-09-09 2024-01-26 中车青岛四方机车车辆股份有限公司 高效液相色谱-串联质谱法测定样品中的4,4-二(二甲氨基)-4-甲氨基三苯甲醇

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2386545A1 (fr) * 1977-04-08 1978-11-03 Merck & Co Inc L'acide 3-(2-aminoethylthio)-6-ethyl-7-oxo-1-azabicyclo(3.2.0)-hept-2-ene-2-carboxylique utile comme medicament

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3928569A (en) * 1972-08-09 1975-12-23 Microbial Chem Res Found Two substances inhibiting beta-lactamase and their production
GB1467413A (en) * 1974-03-28 1977-03-16 Beecham Group Ltd Antibiotics
US3950357A (en) * 1974-11-25 1976-04-13 Merck & Co., Inc. Antibiotics
US4165379A (en) * 1975-11-21 1979-08-21 Merck & Co., Inc. N-acetyl thienamycin
US4162324A (en) * 1975-11-21 1979-07-24 Merck & Co., Inc. Antibiotics 890A1 and 890A3
NL7704040A (nl) * 1976-04-28 1977-11-01 Merck & Co Inc Werkwijze voor het bereiden van nieuwe anti- biotica.
US4162323A (en) * 1977-04-18 1979-07-24 Merck & Co., Inc. Antibiotic N-acetyl-dehydro-thienamycin
US4235922A (en) * 1979-06-15 1980-11-25 Merck & Co., Inc. 3-(2-Aminoethylthio)-6-ethyl-7-oxo-1-azabicyclo [3.2.0]hept-2-ene-2-carboxylic acid

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2386545A1 (fr) * 1977-04-08 1978-11-03 Merck & Co Inc L'acide 3-(2-aminoethylthio)-6-ethyl-7-oxo-1-azabicyclo(3.2.0)-hept-2-ene-2-carboxylique utile comme medicament

Also Published As

Publication number Publication date
AU3459278A (en) 1979-10-04
AU518781B2 (en) 1981-10-22
CA1123767A (fr) 1982-05-18
DK144098B (da) 1981-12-07
SE7803623L (sv) 1978-11-17
CH643262A5 (de) 1984-05-30
AT362059B (de) 1981-04-27
ATA224578A (de) 1980-09-15
IL54118A (en) 1981-09-13
IE780638L (en) 1978-09-30
GR62185B (en) 1979-03-02
IT1113066B (it) 1986-01-20
NL7802976A (nl) 1978-10-03
FR2408608B1 (fr) 1986-05-16
IT7821748A0 (it) 1978-03-30
GB1598062A (en) 1981-09-16
FI780671A (fi) 1978-10-01
LU79351A1 (fr) 1979-03-26
FI59813C (fi) 1981-10-12
AR219738A1 (es) 1980-09-15
DK143678A (da) 1978-10-01
DE2813922A1 (de) 1978-10-19
IE46369B1 (en) 1983-05-18
NZ186830A (en) 1981-12-15
NO781076L (no) 1978-10-03
DK144098C (da) 1982-06-01
FI59813B (fi) 1981-06-30
PT67848B (en) 1979-09-28
US4318916A (en) 1982-03-09
PT67848A (en) 1978-04-01

Similar Documents

Publication Publication Date Title
FR2414039A1 (fr) Derives de prostacycline, leur procede de preparation et leurs applications en therapeutique
FR2385722A1 (fr) Nouveaux derives de cephalosporine, leur procede de preparation et leur application en therapeutique
FR2420529A1 (fr) Derives de n-alkylpiperidine et leur utilisation pour inhiber l'augmentation de sucre dans le sang
FR2392016A1 (fr) Derives de mevalonolactone, leur procede de preparation et leur application therapeutique
FR2401159A1 (fr) Derives de 3-(1h-tetrazol-5-yl)-4h-pyrido(1,2-a)pyrimidine-4-one, leur procede de preparation et leur activite therapeutique
FR2449089A1 (fr) B-lactames derives de l'acide penicillanique, leur preparation et leurs utilisations therapeutiques
IE34896L (en) 1, 4-dihydropyridines
FR2401165A1 (fr) Procede de preparation d'analogues de thiadiazolylcephalosporine et nouveaux produits ainsi obtenus, a activite antibacterienne
FR2384774A1 (fr) Nouveaux derives de la morphine et application a titre de medicament.
FR2409989A1 (fr) Pyrazoles substitues en position 4, leur preparation et leur utilisation therapeutique
FR2405246A1 (fr) Nouveaux derives de pyrrole, leur procede de preparation et leurs applications en therapeutique
FR2384811A1 (fr) Derives de la neocarzinostatine, leur application therapeutique et leur procede de preparation
FR2408608A1 (fr) Nouvel antibiotique denomme ps-5 et ses derives doues d'activite inhibitrice de la b-lactamase et leur procede de preparation
FR2408584A1 (fr) Composes guanidinobenzoiques et possedant une activite antifibrinolysine et antitrypsine et leur procede de preparation
FR2381753A1 (fr) Nouveaux derives de la pyrrolidine, leur procede de preparation et leur application en therapeutique
FR2383930A1 (fr) Ethers aminoalcoyliques de pyridinyle, leurs procedes d'obtention et preparations pharmaceutiques les contenant
FR2412553A1 (fr) Nouveaux antibiotiques de cephalosporine a large spectre
FR2415097A1 (fr) Derives de l'anthraquinone, leur procede de preparation et leur utilisation
FR2409753A1 (fr) Medicaments a base d'un nouveau derive de la pyridine
FR2416886A1 (fr) Nouveaux derives de la 3-phenyl-tetrahydropyridine et leurs sels, procedes de preparation et application a titre de medicaments
FR2413370A1 (fr) Trans-4a-aryl-octahydro-1h-2-pyrindines et leur utilisation therapeutique
FR2355831A1 (fr) Derives de benzazocine, leur procede de preparation et leur application therapeutique
FR2415107A1 (fr) Derives de 5-phenethyl-2-oxazolidone, leur procede de preparation et leur application en therapeutique
FR2410640A1 (fr) Derives de phenoxyalcanolamines, leur preparation et leurs utilisations therapeutiques
FR2455596A1 (fr) Nouveaux antibiotiques presentant une activite antibacterienne, leur procede de production, leur souche servant a leur obtention et les compositions pharmaceutiques les contenant

Legal Events

Date Code Title Description
CD Change of name or company name
ST Notification of lapse